Expertise in
4
conditions

Dr. Richard Jennelle

Radiation Oncology
USC Norris Comprehensive Cancer Center And Hospital
1441 Eastlake Ave, 
Los Angeles, CA 
Expertise in
4
conditions
USC Norris Comprehensive Cancer Center And Hospital
1441 Eastlake Ave, 
Los Angeles, CA 

Overview

Richard Jennelle is a Radiation Oncologist practicing medicine in Los Angeles, California.

Dr. Jennelle is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Choroid Plexus Carcinoma, Metastatic Uveal Melanoma, and Malignant Peripheral Nerve Sheath Tumor.

He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 5 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

USC Norris Comprehensive Cancer Center and Hospital
1441 Eastlake Ave, Los Angeles, CA 90089
Other Locations
Keck Medical Center At Usc Radiology
1441 Eastlake Ave, Los Angeles, CA 90089

Additional Areas of Focus

Dr. Jennelle has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2026
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Enrollment Status: Active_not_recruiting
Publish Date: May 27, 2026
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
View 4 Less Clinical Trials

22 Total Publications

Anterior plaque brachytherapy placement for treatment of iris and iridociliary melanomas - Surgical procedure and institutional experience.
Anterior plaque brachytherapy placement for treatment of iris and iridociliary melanomas - Surgical procedure and institutional experience.
Journal: Indian journal of ophthalmology
Published: March 28, 2023
Similar Doctors
Expertise in
21
conditions
Dr. Mitchell R. Kamrava
Radiation Oncology
Expertise in
21
conditions
Dr. Mitchell R. Kamrava
Radiation Oncology
Referral may be required

Cedars-Sinai Radiation Oncology-Los Angeles

8720 Beverly Blvd, 
West Hollywood, CA 
 (10.1 miles away)
310-423-4208
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mitchell Kamrava is a Radiation Oncologist practicing medicine in West Hollywood, California. Dr. Kamrava is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Vaginal Cancer, Prostate Cancer, Prostatectomy, and Vitrectomy.

Expertise in
32
conditions
Dr. Arya Amini
Radiation Oncology
Expertise in
32
conditions
Dr. Arya Amini
Radiation Oncology
Referral may be required

City Of Hope National Medical Center Radiology

1500 Duarte Rd, 
Duarte, CA 
 (14.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arya Amini is a Radiation Oncologist practicing medicine in Duarte, California. Dr. Amini is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Glossectomy, and Penectomy.

Expertise in
10
conditions
Dr. Leslie K. Ballas
Radiation Oncology
Expertise in
10
conditions
Dr. Leslie K. Ballas
Radiation Oncology
Referral may be required

Cedars-Sinai Radiation Oncology-Los Angeles

8720 Beverly Blvd, 
West Hollywood, CA 
 (10.1 miles away)
310-423-4208
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Leslie Ballas is a Radiation Oncologist practicing medicine in West Hollywood, California. Dr. Ballas is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Bladder Reconstruction, and Prostatectomy.

Frequently Asked Questions about Dr. Richard Jennelle

How do I make an appointment with Dr. Richard Jennelle?

You can book an appointment with Dr. Richard Jennelle by calling their office at 323-865-3050. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard Jennelle a top-rated expert for Melanoma of the Eye?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard Jennelle is classified as an Distinguished expert for Melanoma of the Eye, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard Jennelle specialize in?

While Dr. Richard Jennelle is a Radiation Oncology, they have specific expertise in Melanoma of the Eye, Choroid Plexus Carcinoma, and Metastatic Uveal Melanoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Richard Jennelle participate in research or clinical trials?

Yes. Dr. Richard Jennelle has published 22 articles and abstracts on conditions like Melanoma of the Eye. You can view a list of Dr. Richard Jennelle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard Jennelle accept my insurance?

Dr. Richard Jennelle accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 323-865-3050 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jennelle's expertise for a condition
ConditionClose
    View All 83 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile